FDA panel recommends CBD for pediatric seizure disorders

By Kari Oakes  |  Clinical Neurology News  | REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING Advisors to the Food and Drug Administration have found a generally favorable benefit-risk profile for cannabidiol oil solution in the treatment of two forms of severe pediatric seizure disorders. The drug is under expedited review by the agency.In a unanimous…